Add like
Add dislike
Add to saved papers

Relevance of cortical arousals for risk stratification in sleep apnea: a three cohort analysis.

STUDY OBJECTIVES: There is uncertainty on best approaches for defining apnea-hypopnea events. To clarify the contributions of desaturation vs arousal to defining hypopneas, we examined the associations of events with desaturation (≥3%) but not arousal (AHI≥3%Only ) versus events with arousals but no desaturation (AHIArOnly ) with obstructive sleep apnea (OSA)-related comorbidities and incident cardiovascular disease (CVD) across multiple cohorts.

METHODS: In the Sleep Heart Health Study (SHHS, N=5473), the Multi-Ethnic Study of Atherosclerosis (MESA, N=1904), and the Osteoporotic Fractures in Men Study (MrOS, N=2685), we examined the independent associations of AHI≥3%Only and AHIArOnly with hypertension, diabetes, and daytime sleepiness, and incident CVD.

RESULTS: After adjusting for covariates and AHI based on events with EEG arousal (regardless of desaturation), AHI≥3%Only was associated with hypertension in SHHS (Odds Ratio, OR: 1.12; 95% confidence interval: 1.04,1.21), per 1SD increase). Similar associations were observed in MESA and MrOS, as well as for associations with diabetes (OR: 1.30; 1.09,1.54 and 1.25; 1.07,1.47, respectively), sleepiness (OR: 1.19; 1.00,1.41 and 1.17; 1.01-1.35), and incident CVD (hazard ratio: 1.37; 1.05,1.77 and 1.14; 1.00,1.29). In contrast, after adjusting for events with desaturation (regardless of arousal), AHIArOnly was unassociated with these outcomes. In SHHS, greater baseline OSA severity was associated with a reduction in arousal frequency over 5 years (p<0.0001).

CONCLUSIONS: In middle-aged and older individuals, addition of events with arousals does not improve the strength of associations with comorbidities or incident CVD. Research is needed to understand generalizability to younger individuals and the mechanistic role of arousals in OSA.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app